Myelodysplastic Syndrome (MDS) Panel by FISH
Also known as: FISH MDS P
Use
The Myelodysplastic Syndrome (MDS) Panel by FISH is used in conjunction with conventional cytogenetics for the diagnosis, prognosis, and monitoring of Myelodysplastic Syndromes. This test provides insights into genetic abnormalities that may influence the clinical course and treatment decisions for patients with MDS, including detecting specific chromosomal deletions and trisomies associated with the disease.
Special Instructions
Not provided.
Limitations
This test is intended for clinical purposes and was developed and its performance characteristics determined by ARUP Laboratories. However, it has not been cleared or approved by the US Food and Drug Administration. The analysis may not detect all relevant chromosomal abnormalities and should be correlated with clinical and other laboratory findings. The presence of trisomy 8 as a sole abnormality may not be definitive for MDS diagnosis without morphological criteria.
New York Approved
Methodology
Chromosomal / Cytogenetics (FISH)
Biomarkers
LOINC Codes
- 62367-8 - Chrom analy pnl FISH
Result Turnaround Time
3-9 days
Related Documents
For more information, please review the documents below
Specimen
Bone Marrow
Volume
3 mL
Minimum Volume
1 mL
Container
Green (sodium heparin) tube
Collection Instructions
Nondiluted bone marrow collected in a heparinized syringe is required. Transfer to a green (sodium heparin) tube.
Storage Instructions
Room temperature.
Causes for Rejection
Frozen specimens, paraffin-embedded specimens, clotted specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 48 hours |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant